Feb. 19, 2013
/PRNewswire/ -- BioScrip (NASDAQ: BIOS) today announced that the Company will release its 2012 fourth quarter and year-end financial results on
Monday, March 11, 2013
, after the market closes.
The Company will host a conference call at
8:30 a.m. Eastern Standard Time
Tuesday, March 12, 2013
, President and Chief Executive Officer, and
, Chief Financial Officer, will conduct the call.
Interested parties may participate in the conference call by dialing 800-705-5308 (US), or 303-223-4377 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available for two weeks after the call's completion by dialing 800-633-8284 (US) or 402-977-9140 (International) and entering conference call ID number 21648877. An audio webcast and archive will also be available under the "Investor Relations" section of the BioScrip website at
About BioScrip, Inc.
BioScrip provides comprehensive infusion and home care solutions. By partnering with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers we are able to provide access to infusible medications and management solutions. Our goal is to optimize outcomes for chronic and other complex healthcare conditions and enhance the quality of patient life. BioScrip brings clinical competence in providing high-touch, comprehensive infusion and nursing services to patients in the most convenient ways possible. Through our customer services and treatments we aim to ensure the best possible therapy outcome.
SOURCE BioScrip, Inc.